Remix Therapeutics

Our Science
- Platform
- Pipeline
About Us
Join Us
News
Clinical Trials

Our Science
- Platform
- Pipeline
About Us
Join Us
News
Clinical Trials
Contact

Advisor Category: Board of Directors

Jeff Goater

Kevin Bitterman

Michael Rome

Scott Biller

Peter Smith

Matthew Patterson

Maria Koehler

Search

Recent Posts

A new class of mRNA drugs targets poison exons
Remix Therapeutics™ to Participate in Upcoming Investor Conferences
Remix Therapeutics™ Attains Near-Term Milestone from Roche Collaboration
Remix Therapeutics™ Appoints Maria Koehler, M.D., Ph.D., as an Independent Board Director
Remix Therapeutics™ to Present Preclinical Data Demonstrating Anti-Tumor Activity of REM-422 in AML at the European Hematology Association (EHA) 2024 Congress

Recent Comments

No comments to show.

Archives

September 2024
August 2024
July 2024
June 2024
May 2024
February 2024
January 2024
December 2023
September 2023
May 2023
March 2023
January 2023
December 2022
May 2022
March 2022
February 2022
January 2022
December 2021
August 2021
March 2021
December 2020

Categories

News
Press Release
Publication

Remix Therapeutics

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

Our Science
About Us
Join Us
News
Clinical Trials
Contact

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

© 2023 Remix Therapeutics, Inc. All Rights Reserved